Use of terbinafine in rare and refractory mycoses (Q37071133)

18 August 2017

1 reference

title

Use of terbinafine in rare and refractory mycoses (English)

1 reference

18 August 2017

0 references

3

Jack D Sobel

1 reference

18 August 2017

Sanjay G Revankar

1

1 reference

PubMed ID

18230029

18 August 2017

Michael D Nailor

series ordinal

2

1 reference

18 August 2017

1 February 2008

1 reference

18 August 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

18 August 2017

3

1 reference

18 August 2017

1

1 reference

18 August 2017

9-17

1 reference

Amphotericin B: time for a new "gold standard".

18 August 2017

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Voriconazole: a new triazole antifungal agent

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

The lipid formulations of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Terbinafine in the treatment of onychomycosis: a review of its efficacy in high-risk populations and in patients with nondermatophyte infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Terbinafine: mode of action and properties of the squalene epoxidase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Susceptibility testing of sequential isolates of Aspergillus fumigatus recovered from treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

In-vitro activities of terbinafine, itraconazole and amphotericin B against Aspergillus and Cladosporium species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Antifungal susceptibilities of the species of the Pseudallescheria boydii complex

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Inactivity of terbinafine in a rat model of pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Global overview of Lamisil.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Doubled dose of oral terbinafine is required for Microsporum canis tinea capitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Aspergillus versicolor infection of the external auditory canal successfully treated with terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Treatment of chromoblastomycosis with terbinafine: a report of four cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Images in clinical medicine. Chromoblastomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Chromoblastomycosis: clinical and mycologic experience of 51 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Exophiala jeanselmei infection in a heart transplant recipient successfully treated with oral terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Fungal keratitis caused by Paecilomyces lilacinus associated with a retained intracorneal hair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Successful treatment of multiple Pseudallescheria boydii brain abscesses and ventriculitis/ependymitis in a 2-year-old child after a near-drowning episode

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Recurrent subcutaneous infection due to Scopulariopsis brevicaulis in a liver transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Comparative evaluation of the efficacy and safety of two doses of terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Clinical efficacy and safety of oral terbinafine in fungal mycetoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Terbinafine-associated hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Terbinafine-induced hepatic failure requiring liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Persistent impairment of taste associated with terbinafine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Terbinafine-associated taste disturbance with normal taste threshold scores

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

In vitro susceptibilities of 11 clinical isolates of Exophiala species to six antifungal drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

Oral terbinafine for treatment of pulmonaryPseudallescheria boydii infection refractory to itraconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.9

21 January 2018

Identifiers

DOI

10.2217/17460913.3.1.9

1 reference

18 August 2017

1 reference

PubMed ID

18230029